Last news
Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

Notified -...

Bitget Emerges as a Leading TradFi Trading Venue With Nearly $70B in Q2 Perpetual Volume, TokenInsight Report Finds

Bitget Emerges as a Leading TradFi Trading Venue With Nearly $70B in Q2 Perpetual Volume, TokenInsight Report Finds

Notified -...

Bitget Enhances Algorithmic Trading Experience with Siebly.io SDK Integration

Bitget Enhances Algorithmic Trading Experience with Siebly.io SDK Integration

Notified -...

eXp Realty Expands Investment in Latin America with First Spanish-Language eXpcon

eXp Realty Expands Investment in Latin America with First Spanish-Language eXpcon

Notified -...

Bitget Launches Industry-First Quanto Perpetual Futures for TradFi Assets

Bitget Launches Industry-First Quanto Perpetual Futures for TradFi Assets

Notified -...

Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange

Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange

Notified -...

OpenFX to Offer NGOs Cross-Border FX at Cost

OpenFX to Offer NGOs Cross-Border FX at Cost

Notified -...

LEPAS: True Elegance Lies in the Composure of Intelligent Technology

LEPAS: True Elegance Lies in the Composure of Intelligent Technology

Notified -...

1 2 3 4 5 6 7 8 9 10 ... 1153
menu
menu